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Therapies based on the impairment of reconsolidation or the enhancement of extinction offer the possibility of decreasing the persistent
recollection of distressing memories. However, the direct interplay between reconsolidation and extinction has rarely been considered.
Previously, we reported that reactivation induces reconsolidation of fear extinction memory. Here, using a step-down inhibitory avoid-
ance learning paradigm in rats, we show that intrahippocampus infusion of function-blocking anti-BDNF antibody immediately or 6 h
after extinction memory reactivation impairs the reconsolidation of extinction. Extinction memory reactivation increases proBDNF,
BDNF, and tropomyosin receptor kinase B (TrkB) phosphorylation levels in dorsal CA1, while blocking BDNF maturation in the hip-
pocampus with plasminogen activator inhibitor 1 hinders the persistence of extinction and induces the recurrence of fear. Moreover,
coinfusion of recombinant BDNF (0.25 g/side) after extinction memory reactivation impedes the recovery of the avoidance response
induced by inhibiting gene expression and protein synthesis in the dorsal hippocampus. Our findings unravel a new role for BDNF,
suggesting that this neurotrophin is necessary and sufficient to maintain the reactivated fear extinction engram.
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Introduction
Repeated unreinforced reexposure to the conditioned stimulus
induces extinction of conditioned fear. This protein synthesis-
dependent process creates an inhibitory memory that competes
with, but does not destroy, the original one. Instead, brief reex-
posure to the conditioned stimulus results in reconsolidation of
the learned response. Reconsolidation restabilizes the trace labi-
lized during unreinforced retrieval and, depending on the condi-
tions prevailing at that moment, can also strengthen or update
the reactivated memory engram. Blockade of memory reconsoli-
dation and enhancement of extinction learning offer the thera-
peutic possibility of diminishing the impact caused by the
intrusive recollection of traumatic events (Parsons and Ressler,
2013). However, the direct interplay between reconsolidation
and extinction has seldom been analyzed. Previously, we demon-
strated that fear extinction memory can undergo protein
synthesis-dependent reconsolidation in the hippocampus (Ros-
sato et al., 2010). This suggests that maintenance of fear extinc-
tion memory can be modulated upon its reactivation, and
indicates that understanding the molecular bases of extinction
memory reconsolidation can lead to pharmacological strategies
for increasing the persistence of extinction and therefore help
post-traumatic stress disorder patients to overcome the recur-
rence of disturbing recollections.
BDNF is a keymember of the neurotrophic family of signaling
proteins. In addition to its well-documented participation in
neuronal proliferation and survival, BDNF regulates synaptic
plasticity and memory storage and is linked to fear extinction
(Bekinschtein et al., 2008a; Panja and Bramham, 2014; Rosas-
Vidal et al., 2014). Intrahippocampus administration of BDNF
induces extinction of conditioned fear even in the absence of
extinction training (Peters et al., 2010) and rescues the late-phase
of long-term potentiation as well as the amnesia caused by
protein synthesis inhibitors (Pang et al., 2004; Bekinschtein et
al., 2008b). Actually, hippocampus-specific deletion of BDNF
impairs aversive memory extinction (Heldt et al., 2007).
Therefore, we posited that BDNF is also responsible for sus-
taining avoidance extinction after reactivation. If this hypoth-
esis is true, then impairing BDNF function upon reactivation
of extinction memory should recover the learned fear re-
sponse. Furthermore, when administered at the moment of
fear extinction reactivation, exogenous BDNF should suffice
to prevent the reappearance of fear caused by blocking extinc-
tion memory reconsolidation.
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Materials andMethods
Subjects, surgery, and drug infusion procedures. The subjects were experi-
mentallynaive3-month-oldmaleWistarrats,weighting280–310 g at the start
of the experiments. Theywere housed in groups of 5, keptwith free access
to water and food in a holding room maintained at 22°C–23°C on a
normal light cycle (12 h light:12 h dark; lights on at 6.00 A.M.), and
implanted with 22-gauge guides aimed to the
CA1 region of the dorsal hippocampus at ste-
reotaxic coordinates: anteroposterior, 4.2;
laterolateral, 3.0; dorsoventral, 3.0. The
animals were allowed to recover from surgery
for 4 d before any other procedure. At the time
of drug delivery, infusion cannulas were tightly
fitted into the guides and injections (1 l/side)
performed over 60 s with a microinjection
pump. The cannulas were left in place for 60
additional seconds to minimize backflow. At
the end of surgery, animals were injectedwith a
single dose of meloxicam (0.2 mg/kg) as anal-
gesic. Behavioral procedures commenced 5–7
d after surgery. The placement of the cannulas
was verified postmortem: 2–4 h after the last
behavioral test, 1 l of a 4% methylene-blue
was infused as described above and the exten-
sion of the dye 30 min thereafter taken as an
indication of the presumable diffusion of the
previously given drug. Only data from animals
with correct implants were analyzed.
Inhibitory avoidance (IA) training. After re-
covery from surgery, animals were handled
once a day for 2 d and then trained in the one-
trial step-down IA task during the light phase
of the subjective day (between 9:00 A.M. and
11:00A.M.). The training apparatus was a 50
25  25 cm Plexiglas box with a 5 cm-high,
8-cm-wide, and 25-cm-long platform on the
left end of a series of bronze bars that made up
the floor of the box. For training, animals were
placed on the platform facing the left rear cor-
ner of the training box and, when they stepped
down and placed their four paws on the grid,
received a 2 s 0.5 mA scrambled footshock and
were immediately withdrawn from the training
box.
IA memory extinction procedure. To extin-
guish the learned avoidance response, rats
trained in IA were submitted to 5 unreinforced
test sessions 24 h apart. For this purpose, the
animals were put back on the training box plat-
form until they stepped down to the grid. No
footshock was given, and the animals were al-
lowed to explore the training apparatus freely
for 30 s after they had stepped down. During
this time, the animals stepped up onto the plat-
form and down again several times. To reacti-
vate the extinctionmemory trace, 24 h after the
last extinction training session, the animals
were put on the training box platform until
they stepped down and, right after that, were
removed from the training box. In some exper-
iments, the animals were submitted to a second
extinction protocol after memory reactivation.
Drugs. Anisomycin (ANI; 160 g/side,
Sigma-Aldrich), -amanitin (AMA; 45 ng/
side, Sigma-Aldrich), AP5 (5 g/side, Sigma-
Aldrich), and plasminogen activator inhibitor
1 (PAI-1; 50 ng/side, Sigma-Aldrich) were dis-
solved according to the manufacturer’s in-
structions and stored protected from light at
20°C until use. Right before that, an aliquot was thawed and diluted to
working concentration in 0.1% DMSO in saline, pH 7.2. The doses used
were determined based on pilot experiments and previous studies show-
ing the behavioral and biochemical effects of each compound (Bekinsch-
tein et al., 2007; Revest et al., 2014). Human recombinant BDNF was
Figure 1. Retrieval induces reconsolidation of fear extinction memory. A, Extinction of inhibitory avoidance memory is not prone to
spontaneous recovery, reinstatement, or renewal, and requires NMDAr activation in the dorsal hippocampus. Animals were trained in IA
(TR)and,beginning24hlater,weresubmittedtoonedailyextinctionsession(EXT) inthetrainingcontext(ContextA) for5d.After that, the
animals were randomly assigned to one of three different experimental groups. The first group (Recovery) was tested for retention in
Context A7or 14dafter the last extinction session. The animals in the secondgroup (Reinstatement) received anoncontingent footshock
(US) identical in intensity andduration to that receivedduring IA training, but in adifferent context, 24hafter extinction, andwere tested
forretentioninContextA1or7dlater.Theanimals inthethirdgroup(Renewal)weretreatedastheanimals intheRecoveryGroupbutwere
tested for retention inContextB.B, Animals trained in IAwere submitted toonedaily extinction session in the trainingcontext for5d (first
session 24 h after IA training). Immediately after each session, the animals received bilateral intra-CA1microinfusions of vehicle (VEH
0.1% DMSO in saline) or AP5 (5g/side). Data are expressed as mean SEM. n 7 per group. *p 0.05 (Holm-Sidak’s multiple-
comparisontestaftertwo-wayrepeated-measuresANOVA).C, Inhibitionofgeneexpressionorproteinsynthesis indorsalCA1immediately
afterfearextinctionmemoryreactivationrecoversthelearnedfearresponse.AnimalsweretrainedinIA(TR)and,beginning24hlater,were
submitted to one daily extinction session for 5 d. Twenty-four hours after the last extinction session, extinctionmemory was reactivated
(RA) and, immediately or 6 h later, the animals received bilateral intra-CA1microinfusions of vehicle (VEH 0.1% DMSO in saline), the
protein synthesis inhibitor ANI (160g/side), or themRNA synthesis blocker AMA (45 ng/side). Retentionwas assessed 1 or 7 d after RA.
Data are expressed as mean SEM. n 8–12 per group. *p 0.05 (Dunnett’s multiple-comparison test after ANOVA). **p 0.01
(Dunnett’smultiple-comparison test after ANOVA). ***p 0.001 (Dunnett’smultiple-comparison test after ANOVA).
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from Sigma-Aldrich (lot #SLBC5725V), and
function-blocking anti-BDNF antibody (BD-
NFab) was from EMD Millipore. They were
dissolved at working concentration in sterile
saline and stored at 20°C until use. BDNF
was administered at 0.25 g/side, a dose that
has been previously shown to reverse the am-
nesic effect caused by inhibition of hippocam-
pal protein synthesis (Bekinschtein et al.,
2008b). BDNFab was administered at 0.5 g/
side, a dose that has been previously shown to
hinder BDNF signaling in the dorsal hip-
pocampus (Bekinschtein et al., 2007).
Immunoblotting. Animals were killed by de-
capitation and the CA1 region of the dorsal
hippocampus rapidly dissected out and ho-
mogenized in ice-chilled homogenization buf-
fer (20 mM Tris-HCl, pH 7.4, containing 0.32
M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM
PMSF, 10 g/ml aprotinin, 15 g/ml leupep-
tin, 10 g/ml bacitracin, 10 g/ml pepstatin,
50mMNaF, and 1mM sodium orthovanadate).
Protein concentration was determined using
the BCA protein assay (Pierce), and equal
amounts of proteins fractionated by SDS-
PAGE before being transferred to PVDFmem-
branes (Immobilon-P, Millipore). After
verification of protein loading by Ponceau S
staining, the blots were blocked in Tween Tris-
HCl buffer saline (TTBS; 100 mm Tris-HCl,
pH7.5, containing 0.9%NaCl and 0.1%Tween
20) and incubated overnight with anti-BDNF
(1:5000 dilution, Santa Cruz Biotechnology),
anti-proBDNF (1:5000 dilution, Sigma-
Aldrich), anti-tropomyosin receptor kinase B
(TrkB) (1:5000 dilution, Sigma-Aldrich), anti-
pTyr515TrkB (1:10,000 dilution, Sigma-
Aldrich), or -tubulin (1:20,000, Abcam). The
blots were washed in TTBS and incubated with HRP-coupled anti-IgG
antibody, washed again, and the immunoreactivity detected using the
West-Pico enhanced chemiluminescence kit (Pierce). Densitometric
analyses were performed with an ImageQuant RT-ECL system (GE
Healthcare).
Results
To test the hypotheses mentioned above, we used a one-trial
step-down IA task in rats. IA training produces a persistent
hippocampus-dependent aversive memory (Bekinschtein et al.,
2008b). However, repeated reexposure to the training apparatus
in the absence of the ensuing footshock induces the NMDAr-
dependent extinction of the IA response (F(1,12) 4.77, p 0.04
for treatment and F(4,48) 2.69, p 0.04 for treatment session
interaction), which is not prone to spontaneous recovery, rein-
statement, or renewal (Fig. 1A,B). Confirming and extending
previous results (Rossato et al., 2010), we found that the protein
synthesis inhibitor ANI (160 g/side) and the mRNA synthesis
blocker AMA (45 ng/side) impaired the retention of extinction
when given in the dorsal hippocampus immediately after extinc-
tionmemory reactivation (F(2,27) 9.64, p 0.0007 and F(2,27)
7.47, p 0.0026 for 1 and 7 d after reactivation, respectively) but
not 6 h thereafter (Fig. 1C), indicating that reconsolidation of
avoidance extinction requires not only protein synthesis but also
gene expression in the hippocampus. We also found that intra-
dorsal hippocampus infusion of BDNFab (0.5 g/side) immedi-
ately (Fig. 2A; t(22) 5.19 and t(22) 4.79; p 0.0001 for 1 and
7d, respectively) or 6 h after extinctionmemory reactivation (Fig.
2A; t(19) 6.01 and t19 4.65; p 0.0001 for 1 and 7 d, respec-
tively) induced the reappearance of the IA response on test ses-
sions performed 1 or 7 d later. BDNFab had no effect on
extinctionmemory persistence when given 12 h after reactivation
or when injected 24 h after the last extinction training trial in the
absence of a behaviorally relevant event, indicating that it did not
alter locomotion,motivation, or anxiety or affected the function-
ality of the hippocampus nonspecifically. Themnemonic effect of
BDNFab cannot be attributed to transient inhibition of extinc-
tion memory expression either, because reextinction of the re-
covered avoidance response necessitated several reexposure
sessions and was blocked by the NMDAr antagonist AP5 (5 g/
side) (Fig. 2B; F(1,20) 10.41, p 0.004 for treatment and F(4,80)
 4.39, p 0.003 for treatment session interaction), exactly as
initial extinction. Extinction memory reactivation increased
proBDNFandBDNF levels, aswell as the phosphorylation of TrkB
at Tyr 515 (pTrkB) in dorsal CA1, but had no effect on total TrkB
expression (Fig. 3A). proBDNF peaked 30 min after reactivation
and remained increased for at least 90 min (F(5,20)  7.02, p 
0.0006). The increases in BDNF (F(5,20) 5.01, p 0.0039) and
pTrkB levels (F(5,20) 5.30, p 0.0029) were slower and reached
a maximum between 180 min and 360 min after reactivation,
probably reflecting the proteolytic conversion of newly synthe-
sized proBDNF to mature BDNF, a key step in BDNF signaling
and memory processing. Indeed, intradorsal hippocampus infu-
sion of the BDNFmaturation blocker PAI-1 (50 ng/side) (Revest
et al., 2014) immediately after extinction memory reactivation
also hampered the persistence of extinction and induced the reap-
Figure 2. BDNF is required for fear extinction memory reconsolidation. A, Blockade of BDNF function immediately or 6 h after
reactivation hinders the persistence of fear extinction memory. Animals were trained in IA (TR) and, beginning 24 h later, were
submitted to one daily extinction session for 5 d. Twenty-four hours after the last extinction session, extinction memory was
reactivated (RA) and, immediately, 6 or 12 h later, the animals received bilateral intra-CA1 microinfusions of vehicle (VEH
control sheep IgG in sterile saline) or BDNFab (0.5g/side). A group of animals was not submitted to the RA session but instead
received BDNFab in dorsal CA1 24 h after the last extinction session (INJ). Retention was assessed 1 or 7 d after RA or INJ. Data are
expressed asmean SEM. n 10–13 per group. ***p 0.001 in two-tailed Student’s t test.B, Animals were trained in IA (TR)
and, beginning24h later,were submitted toonedaily extinction session for 5d. Twenty-fourhours after the last extinction session,
extinction memory was reactivated (RA) and, immediately thereafter, the animals received bilateral intra-CA1 microinfusions of
BDNFab. Beginning 24 h after RA, the animals were submitted to one daily reextinction session in the training context for 5 extra
days. Immediately after each reextinction session, the animals received bilateral intra-CA1 microinfusions of VEH or AP5 (5g/
side). Data are expressed asmean SEM. n 10 per group. **p 0.01 (Holm-Sidak’s multiple-comparison test after two-way
repeated-measures ANOVA).
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pearance of avoidance (Fig. 3B; t(15) 6.27;
p 0.0001 and t(15) 2.70; p 0.016 for 1
and 7 d after reactivation, respectively). Im-
portantly, coinfusion of recombinant
BDNF (0.25 g/side) right after extinction
memory reactivation impeded the recovery
of the learned avoidance response induced
by ANI and AMA, suggesting that BDNF is
sufficient to restabilize the IA extinction
memory trace after reactivation (Fig. 4).
Discussion
Most findings suggest that the persistent
recollection of fearful and aversive experi-
ences can be attenuated by enhancing
extinction learning or by impairingmem-
ory reconsolidation. Our data indicate
that the recurrence of learned fear can be
controlled also by modulating BDNF
Figure 3. Reactivation of fear extinction memory increases BDNF signaling, and inhibition of BDNF maturation blocks fear extinction memory reconsolidation. A, Reactivation of fear
extinction memory increases proBDNF and BDNF levels and induces the phosphorylation of TrkB at Tyr-515 (pTrkB) in dorsal CA1. Rats trained in inhibitory avoidance were submitted to
5 daily extinction sessions (first session 24 h after IA training). Twenty-four hours following the last extinction session, extinction memory was reactivated (RA), and the animals killed
by decapitation at different times thereafter (5–360min). The CA1 region of the dorsal hippocampus was dissected out, homogenized, and used to determine proBDNF, BDNF, pTrkB, TrkB,
and -tubulin levels by immunoblotting. NAI, Naive animals; TR, animals trained in IA and killed 6 d later; EXT, animals trained in IA that were submitted to 5 daily extinction sessions
(first session 1 d after training) and killed 24 h after the last one. Data are expressed as mean SEM. n 5 animals per group. *p 0.05 (Dunnett’s multiple-comparison test after
repeated-measures ANOVA). **p 0.01 (Dunnett’s multiple-comparison test after repeated-measures ANOVA). ***p 0.001 (Dunnett’s multiple-comparison test after repeated-
measures ANOVA). B, Postreactivation infusion of a BDNF maturation blocker hinders the persistence of the reactivated fear extinction trace. Animals were trained in IA (TR) and,
beginning 24 h later, were submitted to one daily extinction session for 5 d. Twenty-four hours after the last extinction session, extinctionmemory was reactivated (RA) and, immediately
thereafter, the animals received bilateral intra-CA1microinfusions of vehicle (VEH 0.1% DMSO in saline) or of the BDNFmaturation blocker PAI-1 (50 ng/side). Retention was analyzed
1 or 7 d later. Data are expressed as mean SEM. n 8 or 9 animals per group. *p 0.05 (two-tailed Student’s t test). ***p 0.001 (two-tailed Student’s t test).
Figure 4. Intra-CA1 infusionof recombinantBDNF reverses the effect of ANI andAMAonextinctionmemory reconsolidation. Animals
were trained in IA (TR) and, beginning 24 h later, were submitted to one daily extinction session for 5 d. Twenty-four hours after the last
extinction session, extinctionmemorywas reactivated (RA), and immediately thereafter theanimals receivedbilateral intra-CA1 infusions
ofvehicle (VEH0.1%DMSOinsaline),ANI (160g/side),AMA(45ng/side),BDNF(0.25g/side),ANIplusBDNF(ANIBDNF),orAMA
plus BDNF (AMABDNF). Retentionwas assessed 1 or 7 d after RA. Data are expressed asmean SEM. n 8–11 per group. ***p
0.001 inDunnet’smultiple-comparison test after ANOVA.
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signaling at the moment of extinctionmemory reactivation. This
initiates a gene expression- and protein synthesis-dependent re-
consolidation process that induces proBDNF, its conversion to
mature BDNF, and the activation of TrkB in the dorsal hip-
pocampus, and is totally hindered by blocking BDNFmaturation
or functionality. Furthermore, pharmacological activation of
BDNF signaling immediately after extinctionmemory expression
precludes the reemergence of fear caused by impairing extinction
memory reconsolidation with inhibitors of mRNA and protein
synthesis, suggesting that BDNF is not only necessary but also
sufficient formaintaining the avoidance extinctionmemory trace
after reactivation. Several plasticity phenomena susceptible to
protein synthesis blockers, including conditioned taste aversion
and spatial memory consolidation as well as synaptic potentia-
tion (Pang et al., 2004; Martínez-Moreno et al., 2011; Ozawa et
al., 2014), are restored by exogenous BDNF, perhaps through a
mechanism involving inhibition of PKM degradation (Mei et
al., 2011). In this respect, it was demonstrated that BDNF is in-
ternalized promptly after exogenous application and becomes
rapidly available for activity-dependent secretion, successfully re-
placing the new synthesis pathway (Santi et al., 2006). Our results
showing that BDNFab, but not AMA or ANI, hinders extinction
memory when given 6 h after reactivation indicate that gene ex-
pression and protein synthesis are dissociated from BDNF at this
time point. On this matter, it was previously shown that BDNF
regulates several plastic mechanisms in a protein-synthesis-
independent manner (Panja and Bramham, 2014). For example,
the rapid increase in synaptophysin and synaptobrevin levels in-
duced by BDNF in hippocampal slices as well as the modulation
of hippocampal high-frequency transmission produced by this
neurotrophin are not prevented by protein synthesis inhibitors
(Gottschalk et al., 1999; Tartaglia et al., 2001). The facilitatory
role of BDNF in the acquisition of fear extinction is well docu-
mented (Andero and Ressler, 2012), and there seems to be a
correlation between post-traumatic stress disorder risk and
BDNF expression levels (Zhang et al., 2014). On the contrary, the
involvement of BDNF in memory reconsolidation has seldom
been demonstrated (Samartgis et al., 2012; Wang et al., 2012;
Giachero et al., 2013). Indeed, it has been repeatedly suggested
that BDNF actually participates inmemory consolidation but not
in reconsolidation (Lee et al., 2004; Lee and Hynds, 2013), which
seems to contradict our results. However, it must be pointed out
that our experiments do not entail the reactivation of a single
memory trace, as is the case for almost all previous studies on the
potential role of BDNF in memory reconsolidation but, instead,
involve two conflicting well-consolidated memories competing
for the control of behavior. Therefore, we think that, at least for
the reconsolidation of extinction memory, it would be too sim-
plistic to talk about BDNF as a “consolidation” or a “reconsoli-
dation” protein. Instead, we prefer to think of BDNF as a key
mediator of the physiological mechanisms controlling the persis-
tent behavioral dominance of extinction memory after its reacti-
vation. In any case, our results unravel a new role for BDNF and
further demonstrate the existence of a hitherto unexplored win-
dow of opportunity for the treatment of anxiety disorders.
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